Literature DB >> 6448573

Moxalactam (6059-S), a new 1-oxa-beta-lactam: binding affinity for penicillin-binding proteins of Escherichia coli K-12.

Y Komatsu, T Nishikawa.   

Abstract

Moxalactam (6059-S) is a new beta-lactam derivative with a structure markedly different from those of penicillins or cephalosporins. The binding activity of 6059-S to penicillin-binding proteins (PBPs) in Escherichia coli K-12 was tested. [14C]benzylpenicillin- or [14C]6059-S-bound inner membrane proteins of E. coli K-12 were rapidly detected without using fluorography. 6059-S had the highest affinity for PBP-3 and -7/8, had a higher affinity than benzylpenicillin for PBP-1A, -1Bs, -4, and -5/6 and a lower affinity for PBP-2, 609134, the 1-thiacephem analog of 6059-S, showed as high an affinity for PBP-1A, -1Bs, -3, and -4 as 6059-S but a lower affinity for PBP-5/6.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6448573      PMCID: PMC283783          DOI: 10.1128/AAC.17.3.316

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Purification to homogeneity and properties of two D-alanine carboxypeptidases I From Escherichia coli.

Authors:  T Tamura; Y Imae; J L Strominger
Journal:  J Biol Chem       Date:  1976-01-25       Impact factor: 5.157

2.  Mutants of Escherichia coli which lack a component of penicillin-binding protein 1 are viable.

Authors:  B G Spratt; V Jobanputra
Journal:  FEBS Lett       Date:  1977-07-15       Impact factor: 4.124

3.  Multiple penicillin-binding components in Bacillus subtilis, Bacillus cereus, Staphylococcus aureus, and Escherichia coli.

Authors:  H Suginaka; P M Blumberg; J L Strominger
Journal:  J Biol Chem       Date:  1972-09-10       Impact factor: 5.157

4.  Properties of the penicillin-binding proteins of Escherichia coli K12,.

Authors:  B G Spratt
Journal:  Eur J Biochem       Date:  1977-01

5.  Isolation of a mutant of Escherichia coli lacking penicillin-sensitive D-alanine carboxypeptidase IA.

Authors:  M Matsuhashi; I N Maruyama; Y Takagaki; S Tamaki; Y Nishimura; Y Hirota
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

6.  Thermosensitive mutation in Escherichia coli simultaneously causing defects in penicillin-binding protein-1Bs and in enzyme activity for peptidoglycan synthesis in vitro.

Authors:  S Tamaki; S Nakajima; M Matsuhashi
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  Enzymatic studies on the mechanism of action of cefoxitin. Correlation between the affinities of cefoxitin to penicillin-binding proteins and its rates of inhibition of the respective penicillin-sensitive reactions in E. coli.

Authors:  M Matsuhashi; S Tamaki
Journal:  J Antibiot (Tokyo)       Date:  1978-12       Impact factor: 2.649

8.  Mutants of Escherichia coli lacking in highly penicillin-sensitive D-alanine carboxypeptidase activity.

Authors:  M Matsuhashi; Y Takagaki; I N Maruyama; S Tamaki; Y Nishimura; H Suzuki; U Ogino; Y Hirota
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

  8 in total
  6 in total

1.  Penetration of moxalactam into its target proteins in Escherichia coli K-12: comparison of a highly moxalactam resistant mutant with its parent strain.

Authors:  Y Komatsu; K Murakami; T Nishikawa
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

2.  Effect of 6059-S, a noval oxacephem, on cross-linking reaction of peptidoglycan biosynthesis in Escherichia coli, Pseudomonas aeruginosa and Serratia marcescens.

Authors:  N Takata; M Ogawa; G Kosaki; H Suginaka
Journal:  Arch Microbiol       Date:  1981-09       Impact factor: 2.552

3.  In vitro antagonism of beta-lactam antibiotics by cefoxitin.

Authors:  C C Sanders; W E Sanders; R V Goering
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

4.  In vitro activity of moxalactam and mecillinam, singly and in combination, against multi-drug-resistant Enterobacteriaceae and Pseudomonas species.

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

5.  Quality control of moxalactam susceptibility disks.

Authors:  A L Barry; D A Preston; R N Jones; T L Gavan; C Thornsberry
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

Review 6.  Moxalactam (latamoxef). A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A A Carmine; R N Brogden; R C Heel; J A Romankiewicz; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-10       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.